E.g., 03/28/2020
E.g., 03/28/2020
Titlesort descending Category Credit Event Date Price
Get the Facts: 2019 AUA/SUFU Diagnosis and Treatment of Non-Neurogenic OAB in Adults Guideline Update Webcast (2020)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 Review and explore the recent changes to the 2019 AUA/SUFU Clinical Guideline on Diagnosis and Treatment of Non-Neurogenic OAB in Adults. Interactive, live interviews with subject matter experts will:
Highlights in Renal Cell Carcinoma: Coordination of Care & the Patient's Journey (2018)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 The "Live from AUA2018" Highlights in Renal Cell Carcinoma series is comprised of three panel discussions which will focus on:
Highlights in Renal Cell Carcinoma: The Evolving Landscape of Adjuvant Therapy (2018)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 The "Live from AUA2018" Highlights in Renal Cell Carcinoma series is comprised of three panel discussions which will focus on:Discussing the evolving landscape of adjuvant therapy for the treatment of kidney cancer and debating the elements of disagreement in this area.Differentiating the roles of urologist and medical oncologist in the care of patients with kidney cancer.Appreciating the patient’s journey through RCC and identifying their needs as it relates to the coordination of care between the urologists and medical oncologists. 
Highlights in Renal Cell Carcinoma: The Roles of the Urologist and Medical Oncologist (2018)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 The "Live from AUA2018" Highlights in Renal Cell Carcinoma series is comprised of three panel discussions which will focus on:
Highlights in the Medical Management of Urothelial Carcinoma: Advanced and Metastatic Urothelial Carcinoma (2019)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 The Live from AUA2019: Highlights in the Medical Management of Urothelial Carcinoma is compromised of two panel discussions filmed at the 2019 AUA Annual Meeting in Chicago focused on optimizing the treatment of urothelial carcinoma.  The panel discussions will present the latest developments in the:1) Management of Non-Muscle Invasive Urothelial Carcinoma (see below for a link to the activity)2) Management of Advanced and Metastatic Urothelial Carcinoma
Highlights in the Medical Management of Urothelial Carcinoma: Non-Muscle Invasive Urothelial Carcinoma (2019)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 The Live from AUA2019: Highlights in the Medical Management of Urothelial Carcinoma is compromised of two panel discussions filmed at the 2019 AUA Annual Meeting in Chicago focused on optimizing the treatment of urothelial carcinoma.  The panel discussions will present the latest developments in the:1) Management of Non-Muscle Invasive Urothelial Carcinoma 2) Management of Advanced and Metastatic Urothelial Carcinoma (see below for a link to the activity)
Immune Checkpoint Inhibitors in RCC Podcast (2019)
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Non-Physician Participation
$0.00 To encourage consistent, high quality, evidence-based treatment of patients, the AUA is launching a series of podcast episodes designed to improve the ability of the urologist to care for patients with prostate, bladder and kidney cancers. These activities are designed to increase the clinician’s competence in the application of new and emerging treatment options, including their mechanism of action and associated side effects.
Immunotherapy: From Research to Practice Webcast (2017)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 The AUA developed the Emerging Immunotherapeutic Agents for the Treatment of Bladder Cancer initiative to include multiple educational interventions to improve the urologist, medical oncologist, and other healthcare provider's ability to care for patients with bladder cancer. These activities are designed to increase the clinician's competence in the application of new and emerging treatment options, including the sequencing and associated side effects of those options.
Index Volumes 1-37 $0.00 AUA Update Series Index Volumes 1-37
Informe-se: Webinar Sobre a Atualização de 2019 das Diretrizes da AUA/SUFU Para Diagnóstico e Tratamento da BH Não Neurogênica em Adultos - Português...
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
03/30/2020 $0.00 Webinar gratuito!30 de Março de 2020 | 13:00 (ET)
Infórmese de los hechos: Webcast de actualización de la Guía clínica de la AUA/SUFU de 2019 para el diagnóstico y el tratamiento de la vejiga...
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 Analizar y explorar los cambios efectuados recientemente a la Guía clínica de la AUA/SUFU de 2019 sobre el diagnóstico y el tratamiento de la vejiga hiperactiva no neurogénica en adultos. Las entrevistas interactivas en vivo con expertos en la materia:
Integrating Care for Oncology Patients: Establishing a Multidisciplinary Oncology Clinic with Advanced Therapeutics Webcast 077IC (2019)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 This course will provide the framework to create a multidisciplinary clinic for the treatment of urologic malignancies, with representation of urologists, medical oncologists and additional specialists working together in a team-based approach. The course will focus on integration of advanced therapeutics including immune-based therapy where applicable in a multidisciplinary setting.
Intraoperative Ultrasound Video (2017)
    • 1.00 Non-Physician Participation
    • 1.00 AMA PRA Category 1 Credit™
$0.00 Member only benefit! The Doppler and Advanced Techniques presented will instruct participants in the physics, machine settings, probe options and techniques for performing intraoperative ultrasound in the practice of urology. The use of ALARA in the performance of intraoperative ultrasound will be discussed. The surgical techniques for achieving optimal visualization and three-dimensional understanding of urologic anatomy will be discussed. The clinical indications and contemporary capabilities for the performance of intraoperative ultrasound will be presented.
Life Long Learning Knowledge Assessment Course: AUA Guidelines 2018: Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia 044IC...
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$99.00 This course will review the new AUA guidelines on lower urinary tract symptoms associated with benign prostatic hyperplasia or BPH/LUTS. Faculty will explore the rigorous process used in the development of these evidence based guidelines, as well as discuss future research needs. The course will provide a clinical framework for the diagnosis, evaluation, treatment and follow-up of patients with lower urinary tract symptoms associated with benign prostatic hyperplasia or BPH/LUTS based on the best available published literature.
Life Long Learning Knowledge Assessment Course: Complications/General Urology Webcast (2018)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$99.00 This activity was taken from the 2015 Recertification (MOC) Review Course Webcast. The purpose of the AUA Recertification (MOC) Review Course is to prepare attendees for the ABU Recertification Examination. This course will be practice focused and will offer practical and clinically specific updates. It will highlight the AUA guidelines and address general urology practice issues that can be expected on the Recertification Exam.

Pages